Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Keros Therapeutics' stock performance has been volatile
making it tougher for Token
error rate) cut renewal pricing by ~8-12% on average in 2025 contracts
and it was discontinued
Strong IP is vital for securing its competitive advantage
INTEGRAL AD SCIENCE PORTER'S FIVE FORCES TEMPLATE RESEARCH B_91 Keros Therapeutics' stock performance hasDon't Miss the Bigger Picture Integral Ad Science faces intense buyer scrutiny, moderate supplier leverage, high rivalry among ad verification peers, constrained threat from new entrants due to data scale, and evolving substitute risks from walled gardens and AI driven measurement this snapshot highlights strategic pressure points and growth levers. This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to
US$ 99.00
US$ 14.00
US$ 28.08
US$ 38.00
US$ 123.32
US$ 155.00
US$ 511.30
US$ 15.00
